Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A

5(100.0%)

5Total

N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT06226376Not ApplicableCompleted

Mollii Suit and Fibromyalgia (EXOFIB 2)

Role: lead

NCT06535503Recruiting

Clinical Characteristics and Outcomes Among STEMI Patients With Cardiogenic Shock at Abu Dhabi City

Role: collaborator

NCT05817994Withdrawn

Endoscopic Ultrasound Guided Liver Biopsy and Portal Pressure Registry

Role: lead

NCT06665893Not ApplicableCompleted

Local Proof of Concept of Evira in Abu Dhabi Study

Role: lead

NCT05857280Not ApplicableRecruiting

EXOPULSE Mollii Suit, Motor Function & Multiple Sclerosis (EXOSEP 2)

Role: lead

NCT06214975Not ApplicableUnknown

EXOPULSE Mollii Suit, Motor Function & Stroke (EXOSTROKE 2)

Role: lead

NCT05912595Not ApplicableUnknown

EXOPULSE Mollii Suit, Spasticity, Muscular Oxygenation & Multiple Sclerosis (ENNOX 2)

Role: lead

NCT04422418Unknown

Impact of Burnout on Cardiovascular and Immune Biomarkers in Healthcare Professionals - Covid-19 Pandemic in Abu Dhabi

Role: collaborator

All 8 trials loaded